References
- Turco S, King RE. Sterile dosage forms their preparation and clinical application. 3rd ed. Philadelphia: Lea & Febiger; 1987
- Romacker M, Schoenknecht T, Forster R. The rise of prefilled syringes from niche product to primary container of choice: a short history. ONDrugDelivery. Prefilled syringes: the container of choice for today’s injectables. 2008:4–5
- Jones LS, Kaufmann A, Middaugh CR. Silicone oil induced aggregation of proteins. J Pharm Sci 2005;94:918–927
- Liu W, Swift R, Tirraca G, et al. Root cause analysis of tungsten-induced protein aggregation in pre-filled syringes. PDA J Pharm Sci Technol 2010;64:11–19
- Wright JM. Developing containers and devices to meet emerging and evolving parenteral needs. ONDrugDelivery. Prefilled syringes: with the patient and safety at its core, the market re-aligns. 2011:22–24
- Kettelhoit S. Industrielle Herstellung von Glassspritzen. Pharm Ind 2008;70:1261–1269
- Novak W. Fertigspritzen aus Glas - Herstellen, Befullen, und Verschliessen. Pharm Ind 2010;72:1059–1068
- Production Forma 3s Glass Syringes. Schott products and applications; 2013. Available from: http://www.us.schott.com/pharmaceutical_packaging/english/about_us/videos.html
- Syringe Production Video. Gerresheimer News and Events 2007–2013. Available from: http://www.gerresheimer.com/en/news-events/press-service/videos.html
- Pharma Profil. OPTIMA – excellence in pharma. Available from: http://www.optima-packaging-group.de/opg/pharma/en/brands/brands.php5?HM=2&UM=1&UUM=0&tID=2
- Filling and closing ready to use syringes in nests. Ilshofen, Germany: Bausch & Stroebel Precision to the Highest Standard. Available from: http://www.bausch-stroebel.com/en/filling_and_closing--ene_fillclo.html
- Mackay R. Special pumps. The practical pumping handbook. Oxford: Elsevier Advanced Technology; 2004:159–160
- Nayak A, Colandene J, Bradford V, Perkins M. Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution. J Pharm Sci 2011;100:4198–4204
- Tyagi AK, Randolph TW, Dong A, et al. IgG particle particle formation during filling pump operation: a case study of heterogeneous nucleation on stainless steel nanoparticles. J Pharm Sci 2009;98:94–104
- Nishimoto N, Maekawa T. Determination of conditions for the production scale sterilization of prefilled syringes. PDA J Pharm Sci Technol 2003;57:378–386
- General Chapter 1 <Injections>. USP36-NF31 Vol. 38; 2013. p. 33
- Li L. Advances in container closure integrity testing. Sterile product development formulation, process, quality, and regulatory considerations. New York: Springer; 2013
- Colas A, Siang J, Ulman K. Silicones in pharmaceutical applications. Part 5: siliconization of parenteral packaging components. Midland (MI): Dow Corning Corporation; 2006
- PDA. Siliconization of parenteral drug packaging components (Technical Report No. 12). J Parenteral Sci Technol 1988;42:S1–S13
- Scott IU, Oden NL, Vanveldhuisen PC, et al. SCORE study peport 7: incidence of intravitreal silicone oil droplets associated with staked-on vs. Luer cone syringe design. Am J Ophthamol 2009;148:725–732
- Bee JS, Nelson SA, Freund E, et al. Precipitation of a monoclonal antibody by soluble tungsten. J Pharm Sci 2009;98:3290–3301
- Jiang Y, Nashe-Samuel Y, Li C, et al. Tungsten-induced protein aggregation: solution behavior. J Pharm Sci 2009;98:4695–4710
- Seidl A, Hainzl O, Richter M, et al. Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity. Pharm Res 2012;29:1454–1467
- Swift R. Prefilled syringes for biopharmaceuticals. Formulation and process development strategies for manufacturing biopharmaceuticals. Hoboken (NJ): John Wiley & Sons, Inc.; 2010:897–916
- Kinney S, Wagner A, Phillips C. A rational approach to determining the maximum allowable gas bubble inside a prefilled syringe to minimize stopper movement & protect product sterility. Drug Deliv Technol 2009;9:42–47
- Yoshino K, Nakamura K, Yamashita A, et al. Functional evaluation and characterization of a newly developed silicone oil-free prefillable syringe system. J Pharm Sci 2014;103:1520–1528
- Chan E, Hubbard A, Sana S, Maa Y-F. Syringe siliconization process investigation and optimization. PDA J Pharm Sci Technol 2012;66:136–150
- Olivier LC, Kendoff D, Wolfhard U, et al. Modified syringe design prevents plunger-related contamination – results of contamination and flow-rate tests. J Hosp Infect 2003;53:140–143
- Golfetto P. Incorporating improved technical features in glass prefillable syringe manufacturing for pharmaceutical use. On Drug Delivery 2010;October:29–32
- Patel SM, Pikal MJ. Emerging freeze-drying process development and scale-up issues. AAPS PharmSciTech 2011;12:372–378
- Giudice EL, Campbell JD. Needle-free vaccine delivery. Adv Drug Deliv Rev 2006;58:68–69